Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) EBT (2022 - 2026)

Envoy Medical's EBT history spans 5 years, with the latest figure at -$6.0 million for Q1 2026.

  • On a quarterly basis, EBT fell 6.37% to -$6.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$24.2 million, a 16.68% decrease, with the full-year FY2025 number at -$23.9 million, down 18.87% from a year prior.
  • EBT hit -$6.0 million in Q1 2026 for Envoy Medical, up from -$6.4 million in the prior quarter.
  • Over the last five years, EBT for COCH hit a ceiling of $12.5 million in Q1 2022 and a floor of -$6.7 million in Q4 2023.
  • Historically, EBT has averaged -$2.3 million across 5 years, with a median of -$4.9 million in 2024.
  • Biggest five-year swings in EBT: plummeted 484.97% in 2023 and later grew 26.63% in 2024.
  • Tracing COCH's EBT over 5 years: stood at -$1.1 million in 2022, then plummeted by 484.97% to -$6.7 million in 2023, then rose by 26.63% to -$4.9 million in 2024, then fell by 29.43% to -$6.4 million in 2025, then grew by 6.67% to -$6.0 million in 2026.
  • Business Quant data shows EBT for COCH at -$6.0 million in Q1 2026, -$6.4 million in Q4 2025, and -$6.2 million in Q3 2025.